APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Therapeutics (DTx) For Mental Health

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digital Therapeutics (DTx) For Mental Health Market Outlook and Growth Opportunities 2026

12 August 2026199 pages

Choose your research edition.

Industry ResearchDigital Therapeutics (DTx) For Mental Health Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Therapeutics (DTx) For Mental Health Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Digital Therapeutics (DTx) For Mental Health Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Therapeutics (DTx) For Mental Health Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Therapeutics (DTx) For Mental Health Market Analysis and Forecast 2026-2032177 pages · $4,950 USD

Market perspective

The global Digital Therapeutics (DTx) For Mental Health market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digital Therapeutics (DTx) For Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digital Therapeutics (DTx) For Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Therapeutics (DTx) For Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digital Therapeutics (DTx) For Mental Health market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digital Therapeutics (DTx) For Mental Health market include WellDoc, Pear Therapeutics, COGNIFIT, Ginger, Propeller Health, 2morrow, Canary Health, Noom and Teladoc Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Digital Therapeutics (DTx) For Mental Health market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digital Therapeutics (DTx) For Mental Health and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digital Therapeutics (DTx) For Mental Health revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digital Therapeutics (DTx) For Mental Health market.

Digital Therapeutics (DTx) For Mental Health Segment by Company

WellDoc

Pear Therapeutics

COGNIFIT

Ginger

Propeller Health

2morrow

Canary Health

Noom

Teladoc Health

Omada Health

Digital Therapeutics (DTx) For Mental Health Segment by Type

Biology Modifying Drugs

Gene Therapies

Cell Therapies

Digital Therapeutics (DTx) For Mental Health Segment by Application

Pharmaceutical Companies

Academic and Research Institutions

Others

Digital Therapeutics (DTx) For Mental Health Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Digital Therapeutics (DTx) For Mental Health status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Digital Therapeutics (DTx) For Mental Health key companies, revenue, market share, and recent developments.

3. To split the Digital Therapeutics (DTx) For Mental Health breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Digital Therapeutics (DTx) For Mental Health market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digital Therapeutics (DTx) For Mental Health significant trends, drivers, influence factors in global and regions.

6. To analyze Digital Therapeutics (DTx) For Mental Health competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Therapeutics (DTx) For Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Therapeutics (DTx) For Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Therapeutics (DTx) For Mental Health.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Therapeutics (DTx) For Mental Health industry.

Chapter 3: Detailed analysis of Digital Therapeutics (DTx) For Mental Health company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Digital Therapeutics (DTx) For Mental Health in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Digital Therapeutics (DTx) For Mental Health in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digital Therapeutics (DTx) For Mental Health Industry Trends Table 2. Digital Therapeutics (DTx) For Mental Health Industry Drivers Table 3. Digital Therapeutics (DTx) For Mental Health Industry Opportunities and Challenges Table 4. Digital Therapeutics (DTx) For Mental Health Industry Restraints Table 5. Global Digital Therapeutics (DTx) For Mental Health Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digital Therapeutics (DTx) For Mental Health Revenue Share by Company (2021-2026) Table 7. Global Digital Therapeutics (DTx) For Mental Health Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Digital Therapeutics (DTx) For Mental Health Key Company Manufacturing Base & Headquarters Table 9. Global Digital Therapeutics (DTx) For Mental Health Company, Product Type & Application Table 10. Global Digital Therapeutics (DTx) For Mental Health Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Digital Therapeutics (DTx) For Mental Health by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Biology Modifying Drugs Table 15. Significant Companies of Gene Therapies Table 16. Significant Companies of Cell Therapies Table 17. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type (2021-2026) Table 21. Global Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Pharmaceutical Companies Table 23. Significant Companies of Academic and Research Institutions Table 24. Significant Companies of Others Table 25. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application (2021-2026) Table 29. Global Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application (2027-2032) Table 30. Global Digital Therapeutics (DTx) For Mental Health Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Digital Therapeutics (DTx) For Mental Health Sales Value Share by Region (2021-2026) Table 33. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Digital Therapeutics (DTx) For Mental Health Sales Value Share by Region (2027-2032) Table 35. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Digital Therapeutics (DTx) For Mental Health Sales Value Market Share by Country (2021-2026) Table 38. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Digital Therapeutics (DTx) For Mental Health Sales Value Market Share by Country (2027-2032) Table 40. WellDoc Company Information Table 41. WellDoc Business Overview Table 42. WellDoc Digital Therapeutics (DTx) For Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. WellDoc Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 44. WellDoc Recent Development Table 45. Pear Therapeutics Company Information Table 46. Pear Therapeutics Business Overview Table 47. Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 49. Pear Therapeutics Recent Development Table 50. COGNIFIT Company Information Table 51. COGNIFIT Business Overview Table 52. COGNIFIT Digital Therapeutics (DTx) For Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. COGNIFIT Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 54. COGNIFIT Recent Development Table 55. Ginger Company Information Table 56. Ginger Business Overview Table 57. Ginger Digital Therapeutics (DTx) For Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Ginger Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 59. Ginger Recent Development Table 60. Propeller Health Company Information Table 61. Propeller Health Business Overview Table 62. Propeller Health Digital Therapeutics (DTx) For Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Propeller Health Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 64. Propeller Health Recent Development Table 65. 2morrow Company Information Table 66. 2morrow Business Overview Table 67. 2morrow Digital Therapeutics (DTx) For Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. 2morrow Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 69. 2morrow Recent Development Table 70. Canary Health Company Information Table 71. Canary Health Business Overview Table 72. Canary Health Digital Therapeutics (DTx) For Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Canary Health Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 74. Canary Health Recent Development Table 75. Noom Company Information Table 76. Noom Business Overview Table 77. Noom Digital Therapeutics (DTx) For Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Noom Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 79. Noom Recent Development Table 80. Teladoc Health Company Information Table 81. Teladoc Health Business Overview Table 82. Teladoc Health Digital Therapeutics (DTx) For Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Teladoc Health Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 84. Teladoc Health Recent Development Table 85. Omada Health Company Information Table 86. Omada Health Business Overview Table 87. Omada Health Digital Therapeutics (DTx) For Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Omada Health Digital Therapeutics (DTx) For Mental Health Product Portfolio Table 89. Omada Health Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Digital Therapeutics (DTx) For Mental Health Product Image Figure 2. Global Digital Therapeutics (DTx) For Mental Health Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Therapeutics (DTx) For Mental Health Market Size (2021-2032) & (US$ Million) Figure 4. Global Digital Therapeutics (DTx) For Mental Health Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Biology Modifying Drugs Image Figure 8. Gene Therapies Image Figure 9. Cell Therapies Image Figure 10. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Digital Therapeutics (DTx) For Mental Health Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type (2021-2032) Figure 13. Pharmaceutical Companies Image Figure 14. Academic and Research Institutions Image Figure 15. Others Image Figure 16. Global Digital Therapeutics (DTx) For Mental Health Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Digital Therapeutics (DTx) For Mental Health Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application (2021-2032) Figure 19. Global Digital Therapeutics (DTx) For Mental Health Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Digital Therapeutics (DTx) For Mental Health Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Digital Therapeutics (DTx) For Mental Health Sales Value (2021-2032) & (US$ Million) Figure 22. North America Digital Therapeutics (DTx) For Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Digital Therapeutics (DTx) For Mental Health Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Digital Therapeutics (DTx) For Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Digital Therapeutics (DTx) For Mental Health Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Digital Therapeutics (DTx) For Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Digital Therapeutics (DTx) For Mental Health Sales Value (2021-2032) & (US$ Million) Figure 28. South America Digital Therapeutics (DTx) For Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Digital Therapeutics (DTx) For Mental Health Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Digital Therapeutics (DTx) For Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Biology Modifying Drugs
  • Gene Therapies
  • Cell Therapies
Applications
  • Pharmaceutical Companies
  • Academic and Research Institutions
  • Others
Companies covered
  • WellDoc
  • Pear Therapeutics
  • COGNIFIT
  • Ginger
  • Propeller Health
  • 2morrow
  • Canary Health
  • Noom
  • Teladoc Health
  • Omada Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digital Therapeutics (DTx) For Mental Health Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digital Therapeutics (DTx) For Mental Health Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Digital Therapeutics (DTx) For Mental Health Market Dynamics
  1. 2.1 Digital Therapeutics (DTx) For Mental Health Industry Trends
  2. 2.2 Digital Therapeutics (DTx) For Mental Health Industry Drivers
  3. 2.3 Digital Therapeutics (DTx) For Mental Health Industry Opportunities and Challenges
  4. 2.4 Digital Therapeutics (DTx) For Mental Health Industry Restraints
3 Digital Therapeutics (DTx) For Mental Health Market by Company
  1. 3.1 Global Digital Therapeutics (DTx) For Mental Health Company Revenue Ranking in 2025
  2. 3.2 Global Digital Therapeutics (DTx) For Mental Health Revenue by Company (2021-2026)
  3. 3.3 Global Digital Therapeutics (DTx) For Mental Health Company Ranking (2024-2026)
  4. 3.4 Global Digital Therapeutics (DTx) For Mental Health Company Manufacturing Base and Headquarters
  5. 3.5 Global Digital Therapeutics (DTx) For Mental Health Company Product Type and Application
  6. 3.6 Global Digital Therapeutics (DTx) For Mental Health Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Digital Therapeutics (DTx) For Mental Health Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Digital Therapeutics (DTx) For Mental Health Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Digital Therapeutics (DTx) For Mental Health Market by Type
  1. 4.1 Digital Therapeutics (DTx) For Mental Health Type Introduction
  2. 4.1.1 Biology Modifying Drugs
  3. 4.1.2 Gene Therapies
  4. 4.1.3 Cell Therapies
  5. 4.2 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Type
  6. 4.2.1 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Type (2021-2032)
  8. 4.2.3 Global Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type (2021-2032)
5 Digital Therapeutics (DTx) For Mental Health Market by Application
  1. 5.1 Digital Therapeutics (DTx) For Mental Health Application Introduction
  2. 5.1.1 Pharmaceutical Companies
  3. 5.1.2 Academic and Research Institutions
  4. 5.1.3 Others
  5. 5.2 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Application
  6. 5.2.1 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Application (2021-2032)
  8. 5.2.3 Global Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application (2021-2032)
6 Digital Therapeutics (DTx) For Mental Health Regional Value Analysis
  1. 6.1 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Region (2021-2032)
  3. 6.2.1 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Region: 2021-2026
  4. 6.2.2 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digital Therapeutics (DTx) For Mental Health Sales Value (2021-2032)
  7. 6.3.2 North America Digital Therapeutics (DTx) For Mental Health Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Digital Therapeutics (DTx) For Mental Health Sales Value (2021-2032)
  10. 6.4.2 Europe Digital Therapeutics (DTx) For Mental Health Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Digital Therapeutics (DTx) For Mental Health Sales Value (2021-2032)
  16. 6.6.2 South America Digital Therapeutics (DTx) For Mental Health Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Sales Value Share by Country, 2025 VS 2032
7 Digital Therapeutics (DTx) For Mental Health Country-level Value Analysis
  1. 7.1 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Country (2021-2032)
  3. 7.2.1 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Country (2021-2026)
  4. 7.2.2 Global Digital Therapeutics (DTx) For Mental Health Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Digital Therapeutics (DTx) For Mental Health Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Digital Therapeutics (DTx) For Mental Health Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Digital Therapeutics (DTx) For Mental Health Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 WellDoc
  2. 8.1.1 WellDoc Company Information
  3. 8.1.2 WellDoc Business Overview
  4. 8.1.3 WellDoc Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  5. 8.1.4 WellDoc Digital Therapeutics (DTx) For Mental Health Product Portfolio
  6. 8.1.5 WellDoc Recent Developments
  7. 8.2 Pear Therapeutics
  8. 8.2.1 Pear Therapeutics Company Information
  9. 8.2.2 Pear Therapeutics Business Overview
  10. 8.2.3 Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Product Portfolio
  12. 8.2.5 Pear Therapeutics Recent Developments
  13. 8.3 COGNIFIT
  14. 8.3.1 COGNIFIT Company Information
  15. 8.3.2 COGNIFIT Business Overview
  16. 8.3.3 COGNIFIT Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  17. 8.3.4 COGNIFIT Digital Therapeutics (DTx) For Mental Health Product Portfolio
  18. 8.3.5 COGNIFIT Recent Developments
  19. 8.4 Ginger
  20. 8.4.1 Ginger Company Information
  21. 8.4.2 Ginger Business Overview
  22. 8.4.3 Ginger Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ginger Digital Therapeutics (DTx) For Mental Health Product Portfolio
  24. 8.4.5 Ginger Recent Developments
  25. 8.5 Propeller Health
  26. 8.5.1 Propeller Health Company Information
  27. 8.5.2 Propeller Health Business Overview
  28. 8.5.3 Propeller Health Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Propeller Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
  30. 8.5.5 Propeller Health Recent Developments
  31. 8.6 2morrow
  32. 8.6.1 2morrow Company Information
  33. 8.6.2 2morrow Business Overview
  34. 8.6.3 2morrow Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  35. 8.6.4 2morrow Digital Therapeutics (DTx) For Mental Health Product Portfolio
  36. 8.6.5 2morrow Recent Developments
  37. 8.7 Canary Health
  38. 8.7.1 Canary Health Company Information
  39. 8.7.2 Canary Health Business Overview
  40. 8.7.3 Canary Health Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Canary Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
  42. 8.7.5 Canary Health Recent Developments
  43. 8.8 Noom
  44. 8.8.1 Noom Company Information
  45. 8.8.2 Noom Business Overview
  46. 8.8.3 Noom Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Noom Digital Therapeutics (DTx) For Mental Health Product Portfolio
  48. 8.8.5 Noom Recent Developments
  49. 8.9 Teladoc Health
  50. 8.9.1 Teladoc Health Company Information
  51. 8.9.2 Teladoc Health Business Overview
  52. 8.9.3 Teladoc Health Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teladoc Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
  54. 8.9.5 Teladoc Health Recent Developments
  55. 8.10 Omada Health
  56. 8.10.1 Omada Health Company Information
  57. 8.10.2 Omada Health Business Overview
  58. 8.10.3 Omada Health Digital Therapeutics (DTx) For Mental Health Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Omada Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
  60. 8.10.5 Omada Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst